The ionization of a series of benzyltriflones ArCH2SO2CF3 (Ar = C6H5, 4-CNC6H4, 4-NO2C6H4, 2,4-(NO2)2C6H3, 2,4,6-(NO2)3C6H2) has been studied kinetically and thermodynamically as well as by 1H, 13C, and 19F NMR in H2O−Me2SO mixtures and/or Me2SO. The findings that the acidity of the triflones is enhanced on going from hydroxylic solvents to Me2SO and that their deprotonation is associated with high Marcus intrinsic reactivities are two major results indicating the presence of a large polarizable charge density at Cα of the carbanionic species. Comparison of the results obtained with those for related arylnitromethane and arylacetonitrile compounds strongly supports this conclusion. NMR data add to the evidence that polarization rather than d−p π-resonance or negative hyperconjugation is the dominant factor in accounting for the capability of the strongly electron withdrawing SO2CF3 group to stabilize negative charge. Altogether, our results lead to a structural picture of the triflone carbanions in solution which does not totally fit the conclusions reached on the basis of solid-state or computed gas-phase studies.

RIP1 kinase regulates necroptosis and inflammation and may play an important role in contributing to a variety of human pathologies, including inflammatory and neurological diseases. Currently, RIP1 kinase inhibitors have advanced into early clinical trials for evaluation in inflammatory diseases such as psoriasis, rheumatoid arthritis, and ulcerative colitis and neurological diseases such as amyotrophic lateral sclerosis and Alzheimer's disease. In this paper, we report on the design of potent and highly selective dihydropyrazole (DHP) RIP1 kinase inhibitors starting from a high-throughput screen and the leadoptimization of this series from a lead with minimal rat oral exposure to the identification of dihydropyrazole 77 with good pharmacokinetic profiles in multiple species. Additionally, we identified a potent murine RIP1 kinase inhibitor 76 as a valuable in vivo tool molecule suitable for evaluating the role of RIP1 kinase in chronic models of disease. DHP 76 showed efficacy in mouse models of both multiple sclerosis and human retinitis pigmentosa.

The catalytic hydrodehalogenation reaction using molecular hydrogen and Pd/C has been revisited. It is shown that the speed of removal of halogen increases with increasing electronegativity I < Br < Cl. Nevertheless, selective dehydrohalogenation in compounds containing other reducible functions can be achieved only with iodine and not with bromine or chlorine. Selective deiodination of iodobenzophenone could be accomplished without reducing the carbonyl group. Hydrogenolysis of azidoiodoaromatic compounds to the corresponding azido compounds is high yielding. This selectivity was exploited for the labeling of benzophenone- and azido-containing compounds by deuterium and tritium.